| GO | Name |
| GO:0000122 | negative regulation of transcription by RNA polymerase II |
| GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO:0001223 | transcription coactivator binding |
| GO:0001227 | DNA-binding transcription repressor activity, RNA polymerase II-specific |
| GO:0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO:0001666 | response to hypoxia |
| GO:0003700 | DNA-binding transcription factor activity |
| GO:0003707 | steroid hormone receptor activity |
| GO:0004879 | nuclear receptor activity |
| GO:0005634 | nucleus |
| GO:0005654 | nucleoplasm |
| GO:0006006 | glucose metabolic process |
| GO:0006355 | regulation of transcription, DNA-templated |
| GO:0006629 | lipid metabolic process |
| GO:0006631 | fatty acid metabolic process |
| GO:0007507 | heart development |
| GO:0008134 | transcription factor binding |
| GO:0008144 | drug binding |
| GO:0008270 | zinc ion binding |
| GO:0008289 | lipid binding |
| GO:0008544 | epidermis development |
| GO:0009267 | cellular response to starvation |
| GO:0009755 | hormone-mediated signaling pathway |
| GO:0010468 | regulation of gene expression |
| GO:0010565 | regulation of cellular ketone metabolic process |
| GO:0010745 | negative regulation of macrophage derived foam cell differentiation |
| GO:0010876 | lipid localization |
| GO:0010887 | negative regulation of cholesterol storage |
| GO:0010891 | negative regulation of sequestering of triglyceride |
| GO:0019216 | regulation of lipid metabolic process |
| GO:0019217 | regulation of fatty acid metabolic process |
| GO:0019902 | phosphatase binding |
| GO:0019904 | protein domain specific binding |
| GO:0030154 | cell differentiation |
| GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO:0031624 | ubiquitin conjugating enzyme binding |
| GO:0032091 | negative regulation of protein binding |
| GO:0032099 | negative regulation of appetite |
| GO:0032868 | response to insulin |
| GO:0032922 | circadian regulation of gene expression |
| GO:0033993 | response to lipid |
| GO:0035095 | behavioral response to nicotine |
| GO:0038023 | signaling receptor activity |
| GO:0042060 | wound healing |
| GO:0042157 | lipoprotein metabolic process |
| GO:0042752 | regulation of circadian rhythm |
| GO:0043565 | sequence-specific DNA binding |
| GO:0044877 | protein-containing complex binding |
| GO:0045070 | positive regulation of viral genome replication |
| GO:0045471 | response to ethanol |
| GO:0045722 | positive regulation of gluconeogenesis |
| GO:0045776 | negative regulation of blood pressure |
| GO:0045820 | negative regulation of glycolytic process |
| GO:0045893 | positive regulation of transcription, DNA-templated |
| GO:0045923 | positive regulation of fatty acid metabolic process |
| GO:0045944 | positive regulation of transcription by RNA polymerase II |
| GO:0046321 | positive regulation of fatty acid oxidation |
| GO:0046889 | positive regulation of lipid biosynthetic process |
| GO:0050728 | negative regulation of inflammatory response |
| GO:0051525 | NFAT protein binding |
| GO:0051898 | negative regulation of protein kinase B signaling |
| GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development |
| GO:0070166 | enamel mineralization |
| GO:0097371 | MDM2/MDM4 family protein binding |
| GO:1900016 | negative regulation of cytokine production involved in inflammatory response |
| GO:1901215 | negative regulation of neuron death |
| GO:1902894 | negative regulation of pri-miRNA transcription by RNA polymerase II |
| GO:1903038 | negative regulation of leukocyte cell-cell adhesion |
| GO:1903427 | negative regulation of reactive oxygen species biosynthetic process |
| GO:1903944 | negative regulation of hepatocyte apoptotic process |
| GO:2000272 | negative regulation of signaling receptor activity |
| GO:2001171 | positive regulation of ATP biosynthetic process |